Amgen Inc (AMGN)
Operating profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 7,258,000 | 7,897,000 | 5,335,000 | 6,005,000 | 5,794,000 |
| Revenue | US$ in thousands | 33,424,000 | 28,190,000 | 26,323,000 | 25,979,000 | 25,424,000 |
| Operating profit margin | 21.71% | 28.01% | 20.27% | 23.11% | 22.79% |
December 31, 2024 calculation
Operating profit margin = Operating income ÷ Revenue
= $7,258,000K ÷ $33,424,000K
= 21.71%
Analyzing Amgen Inc's operating profit margin over the five-year period from 2020 to 2024 reveals fluctuations in the company's profitability. The operating profit margin increased from 22.79% in 2020 to 23.11% in 2021, indicating an improvement in the company's ability to generate profits from its core operations. However, in 2022, the operating profit margin declined to 20.27%, suggesting potential challenges or increased costs impacting profitability.
The year 2023 saw a significant improvement in the operating profit margin, reaching 28.01%, indicating a strong performance and potentially effective cost management strategies. Nonetheless, in 2024, the operating profit margin decreased to 21.71%, signaling a slight dip in profitability compared to the previous year.
Overall, the fluctuating operating profit margin of Amgen Inc over the five-year period indicates varying levels of operational efficiency and profitability, highlighting the importance of monitoring and analyzing financial performance metrics to assess the company's financial health and strategic management of resources.
Peer comparison
Dec 31, 2024